---
title: "Adicet Bio gets until April 6, 2026 to meet Nasdaq bid price rule, moves listing"
url: "https://aibio.space/news/adicet-bio-gets-until-april-6-2026-meet-nasdaq-bid-price-rule-moves/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-10-07"
section: "Listings"
tickers: "NASDAQ:ACET"
source: "https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/acet-20251007.htm"
summary: "Nasdaq granted Adicet Bio an additional 180 calendar days. The stock moves from the Nasdaq Global Market to the Nasdaq Capital Market on October 9, 2025."
---

By the aibio.space news desk.

Sources

- [Adicet Bio, Inc. 8-K (2025-10-07)](https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/acet-20251007.htm)

[ACET](https://aibio.space/companies/adicet-bio/)

2025-10-07

# Adicet Bio gets until April 6, 2026 to meet Nasdaq bid price rule, moves listing

Tickers [ACET](https://aibio.space/companies/adicet-bio/)

Nasdaq granted Adicet Bio an additional 180 calendar days. The stock moves from the Nasdaq Global Market to the Nasdaq Capital Market on October 9, 2025.

## Key facts

- **Company**: Adicet Bio, Inc. (NASDAQ: ACET)

- **News type**: Listings

- **Primary source**: [Adicet Bio, Inc. 8-K (2025-10-07)](https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/acet-20251007.htm)

*The Washington Monument and the city beyond. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Adicet Bio, Inc. has received more time from Nasdaq to lift its share price above the exchange's $1.00 minimum.

On October 7, 2025, Nasdaq granted Adicet an additional 180 calendar days, or until April 6, 2026, to regain compliance with the bid price requirement under Nasdaq Listing Rule 5550(a)(2). The bid price rule requires a listed stock to close at or above $1.00 per share.

The first notice came on April 7, 2025, after Adicet's common stock closed below $1.00 for 30 consecutive business days. That notice gave the company until October 6, 2025 to comply under the Nasdaq Global Market rule.

As part of the extension, the listing moves from the Nasdaq Global Market to the Nasdaq Capital Market at the opening of business on October 9, 2025. The company said the extension notice has no other immediate effect on the listing.

To regain compliance, the stock must close at $1.00 or more for at least 10 consecutive business days before April 6, 2026. If it does not, Nasdaq will send a delisting notice, which Adicet could appeal to a Nasdaq hearings panel.

Adicet said it will monitor its bid price and consider its options. These include "effecting a reverse stock split, if necessary," the company said. A reverse split combines existing shares into fewer shares, which raises the price per share.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

ACET

Adicet Bio, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/adicet-bio-gets-until-april-6-2026-meet-nasdaq-bid-price-rule-moves/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Adicet Bio gets until April 6, 2026 to meet Nasdaq bid price rule, moves listing", 2025-10-07, https://aibio.space/news/adicet-bio-gets-until-april-6-2026-meet-nasdaq-bid-price-rule-moves/